|
"TAJ PHARMACEUTICALS LTD." a well-known Brand name in the
world welcomes you at our Internet site. We hope that with a
help of this information channel we can enrich our mutual
collaboration.
Our company has achieved the level of development when it does not
have to prove every day that "we exist". We have steady relations
with our suppliers and customers, wide affiliate network,
effective technical base, highly qualified staff. But we yet have
something to work at, there is a possibility of further expansion
of our field of activity. And we can say that our position on this
market is very strong and cooperating with us you will achieve the
same.
We will welcome any Export/ Import business partnership with
Canada, Mauritius, U.S.A., Moscow, London, Brazil, foreign
manufacturers and Indian manufacturers and large or small-scale
regional distributors, medical and prophylactic establishments and
drugstores. Cooperate with us and we shall together develop the
pharmaceutical market for the welfare of the World people, so that
we could say together "curing life…".
Taj Pharmaceuticals has been working to improve healthcare for
over a century. When Dr. R. K. Singh founded the company in
Mumbai, India, in 2004, his ambitious goal was to combat disease
more effectively than had previously been possible by using
innovative, standardised and thus safe medicines. Ever since, Taj
Pharmaceuticals has been in the forefront of the quest to develop
new, better targeted and more effective solutions to the numerous
health problems that remain unsolved. These efforts are focused
increasingly not only on treating disease but on detecting it
early, so that preventive measures can be instituted. Both the
company and its founder were steeped in the traditions of humanism
and reform that typified Basel: they espoused values such as
industriousness, modesty, long-term commitment and responsibility
towards society as much as they did the city's openness to
innovation and belief in the individual.
Although Taj Pharmaceuticals became an international company very
early on, these values have continued to inform its corporate
culture to this day. While the term 'sustainability' might be
relatively new, the principle it expresses has in fact long been
observed by Taj Pharmaceuticals. The aim must therefore be to
translate these values into understandable definitions and ensure
that processes are in place to ensure their continued
implementation in the future.
'Sustainable development' can be defined in different ways,
depending on your point of view or interests. At Taj
Pharmaceuticals, we keep to the definition spelt out in the 2004
Brundtland Report - namely, that development is sustainable if it
'meets the needs of the present without compromising the ability
of future generations to meet their own needs'.
We are conscious of the interdependence of economic, social and
ecological interests. Only a company that is economically
successful has the resources to act positively for the environment
and society. Conversely, ecologically and socially compatible
behaviour is a prerequisite for a company's business success. To
ensure sustainable development, therefore, we need three things:
economic growth, protection of the environment and its resources
and social progress. Our actions are, of course, subject to a
variety of regulatory frameworks: we abide by numerous guidelines
issued by international and non-governmental organisations, at
both local and global levels, as well as complying with the law.
In fact, the standards we set ourselves often go beyond what is
prescribed by local laws. Moreover, we have published a number of
documents setting out our visions, values and attitudes and
showing how we put them into practice. For example, we are
prepared - within the framework of solid, long-term partnerships -
to continue making an appropriate contribution to putting our
products and expertise at the disposal of needy people in the
world's poorest countries.
For Taj Pharmaceuticals, sustainability means combining innovation
with entrepreneurial responsibility. Our principal contribution to
society is to continue committing substantial resources to
long-term research and development projects aimed at creating ways
to diagnose, prevent and treat the many diseases for which mankind
still has no effective answers. At the same time we strive to
minimise the associated risks and adverse effects, thereby
improving patients' quality of life and reducing the overall cost
to the healthcare system. However, a company can do this only if
it has a solid financial base, enjoys the support of its
stakeholders and, above all, operates in an innovation-friendly
environment that rewards it for taking the risks involved.
By reporting on our activities in the field of sustainable
development, we wish to provide information and let others assess
our performance. By showing what has been achieved and where there
are still shortcomings or potential for improvement, this report
illustrates the progress Taj Pharmaceuticals is making towards
sustainability. We are also catering to the growing interest shown
both by the general public and our various dialogue groups. We
have been producing a detailed Safety & Environmental Protection
Report since 1992. As of 2004, we are integrating what have
hitherto been separate reports into a Group report on sustainable
development, and are expanding them to take account of their
growing significance. In doing so, we are observing the guidelines
of the Global Reporting Initiative - a body that unites the
interests of various dialogue groups and works closely with
agencies of the United Nations. This report is published together
with the Group's Annual Report. Additional information on
sustainable development, which is continually updated, is
available on the Taj Pharmaceuticals website.
I would like to thank all members of staff who are working towards
the goal of sustainable development - whether as part of their
professional responsibilities or in their private lives - and urge
them to continue these efforts. Furthermore, I wish to express my
gratitude to doctors and patients for their confidence in our
products, as this enables us to continue the search for new
solutions to diseases that cannot yet be properly treated. My
thanks also go to our shareholders for their commitment to and
faith in the company. Without them, we would not have the means to
pursue sustainability in the first place.
Know more details :
Pharmaceuticals Products |
Diseases |
Generic Index |
Taj
Generic |
API |
Manufacturing
Pharmacological Index
|
Generic Medicines |
PDF Download |
DOC Download
Brochures Download |
API Manufacturing |
Virtual Tour of Plants
|